PGRN antibodies entertained a proinflammatory environment in a subgroup of patients with psoriatic arthritis [42], and TNF-α-induced cytotoxicity assays demonstrated that the protective effects of PGRN were inhibited by serum containing PGRN antibodies [42]. Here, TNF is linked to psoriatic arthritis.